UPDATED Sep 29, 2025
Discover U.S. Pharmaceuticals & Biotech Growth Stocks that are on the NYSE and NASDAQ. Sorted by forecasted growth, these Pharmaceuticals & Biotech Stocks have higher than expected earnings or sales growth compared to other companies.
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
SNDL | US$2.74 | 10.9% | 33.0% | US$599.6m | US$4.76 | PS1x | E162.8% | n/a | ||
SBFM | US$1.45 | -4.0% | -54.4% | US$6.7m | US$7.00 | PB0.3x | E147.7% | n/a | ||
TLRY | US$1.85 | 54.2% | 5.1% | US$1.3b | n/a | PS2.5x | E141.3% | n/a | ||
MIRA | US$1.33 | 0% | 2.3% | US$25.2m | US$17.75 | PB44.5x | E112.8% | n/a | ||
EVOK | US$4.82 | -5.9% | 1.3% | US$10.2m | US$18.00 | PB2.3x | E110.9% | n/a | ||
ORGO | US$4.26 | -9.7% | 49.0% | US$520.1m | US$8.00 | PS1.3x | E109.0% | n/a | ||
AZTA | US$28.17 | -10.2% | -41.8% | US$1.3b | US$33.00 | PS1.9x | E102.2% | 0% | ||
HBIO | US$0.44 | -7.7% | -83.7% | US$19.8m | US$2.00 | PB1.2x | E98.7% | n/a | ||
PLX | US$2.16 | 5.9% | 111.8% | US$164.2m | US$14.00 | PE27.4x | E88.4% | n/a | ||
EXAS | US$53.38 | -0.3% | -21.6% | US$10.1b | US$64.65 | PS3.4x | E84.8% | n/a | ||
AMRN | US$16.08 | 4.6% | 28.3% | US$330.9m | US$11.00 | PS1.5x | E83.2% | n/a | ||
AMRX | US$9.87 | -1.3% | 18.6% | US$3.1b | US$12.50 | PE918.5x | E80.6% | 0% | ||
CAI | US$30.00 | -8.9% | n/a | US$8.2b | US$39.38 | PS15.8x | E80.2% | n/a | ||
VTRS | US$9.62 | -1.7% | -17.1% | US$11.1b | US$11.43 | PB0.7x | E77.9% | 5.0% | ||
MYGN | US$7.24 | -7.7% | -73.6% | US$716.4m | US$7.50 | PB1.7x | E77.6% | n/a | ||
OCGN | US$1.45 | 4.3% | 46.1% | US$452.8m | US$6.50 | PS95.3x | E76.9% | n/a | ||
ALDX | US$5.21 | 5.3% | -3.3% | US$304.4m | US$9.50 | PB5.7x | E74.8% | n/a | ||
ITRM | US$0.69 | 0.8% | -37.2% | US$32.1m | US$7.00 | PE-1.3x | E74.8% | n/a | ||
MDXH | US$4.65 | -0.6% | 123.6% | US$229.2m | US$6.04 | PS2.3x | E74.6% | n/a | ||
BRTX | US$1.45 | -2.0% | -16.7% | US$11.4m | US$13.00 | PS19.1x | E74.2% | n/a | ||
OMER | US$4.18 | -2.8% | 5.3% | US$303.5m | US$22.50 | PE-2.1x | E73.5% | n/a | ||
CLGN | US$3.09 | 24.0% | -37.8% | US$39.9m | US$11.56 | PS16.4x | E72.6% | n/a | ||
APRE | US$1.51 | 2.7% | -45.1% | US$8.5m | US$10.50 | PS10.5x | E72.0% | n/a | ||
CLNN | US$5.99 | -6.4% | 30.5% | US$59.2m | US$30.43 | PS210.9x | E72.0% | n/a |